Cancer stem cell drugs target K-ras signaling in a stemness context – Nature.com
|
Cancer stem cell drugs target K-ras signaling in a stemness context
Nature.com Cancer stem cells (CSCs) are considered to be responsible for treatment relapse and have therefore become a major target in cancer research. Salinomycin is the most established CSC inhibitor. However, its primary mechanistic target is still unclear, … |
